Found: 179
Select item for more details and to access through your institution.
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 1, p. 17, doi. 10.3390/cells11010017
- By:
- Publication type:
- Article
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 193, doi. 10.3390/cells10010193
- By:
- Publication type:
- Article
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme.
- Published in:
- BJU International, 2019, v. 123, n. 1, p. 98, doi. 10.1111/bju.14461
- By:
- Publication type:
- Article
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 764, doi. 10.1111/bju.12857
- By:
- Publication type:
- Article
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00376
- By:
- Publication type:
- Article
Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2016, v. 20, n. 3, p. 255, doi. 10.1007/s40291-016-0196-1
- By:
- Publication type:
- Article
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12319-1
- By:
- Publication type:
- Article
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12506-0
- By:
- Publication type:
- Article
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345185, doi. 10.1001/jamanetworkopen.2023.45185
- By:
- Publication type:
- Article
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33774-4
- By:
- Publication type:
- Article
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.716467
- By:
- Publication type:
- Article
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682449
- By:
- Publication type:
- Article
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.564346
- By:
- Publication type:
- Article
Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.567809
- By:
- Publication type:
- Article
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.565857
- By:
- Publication type:
- Article
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01325
- By:
- Publication type:
- Article
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1361010
- By:
- Publication type:
- Article
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
- Published in:
- Therapeutic Advances in Urology, 2023, v. 15, p. 1, doi. 10.1177/17562872231187216
- By:
- Publication type:
- Article
Nadir Prostate-specific Antigen as a Predictor of Survival Outcomes: The PROSPER Trial.
- Published in:
- AUANews, 2023, p. 19
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 8, p. 1213, doi. 10.2967/jnumed.110.076455
- By:
- Publication type:
- Article
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16872, doi. 10.3390/ijms242316872
- By:
- Publication type:
- Article
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12436, doi. 10.3390/ijms241512436
- By:
- Publication type:
- Article
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1096, doi. 10.3390/ijms24021096
- By:
- Publication type:
- Article
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15789, doi. 10.3390/ijms232415789
- By:
- Publication type:
- Article
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14197, doi. 10.3390/ijms232214197
- By:
- Publication type:
- Article
Moving beyond PARP Inhibition: Current State and Future Perspectives in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 7884, doi. 10.3390/ijms22157884
- By:
- Publication type:
- Article
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 10, p. 5145, doi. 10.3390/ijms22105145
- By:
- Publication type:
- Article
Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2569, doi. 10.3390/ijms20102569
- By:
- Publication type:
- Article
Immunotherapy for Prostate Cancer: Where We Are Headed.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 12, p. 2627, doi. 10.3390/ijms18122627
- By:
- Publication type:
- Article
Editorial: Testicular Cancer: New Insights on the Origin, Genetics, Treatment, Fertility, General Health, Quality of Life and Sexual Function.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.
- Published in:
- Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2019.00318
- By:
- Publication type:
- Article
Psychosocial Issues in Long-Term Survivors of Testicular Cancer.
- Published in:
- Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2019.00113
- By:
- Publication type:
- Article
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231161412
- By:
- Publication type:
- Article
Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156147
- By:
- Publication type:
- Article
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079580
- By:
- Publication type:
- Article
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019642
- By:
- Publication type:
- Article
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987654
- By:
- Publication type:
- Article
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7745, doi. 10.3390/curroncol29100612
- By:
- Publication type:
- Article
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 7, p. 1050, doi. 10.1038/s41416-023-02354-3
- By:
- Publication type:
- Article
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.
- Published in:
- Oncology, 2017, v. 92, n. 5, p. 269, doi. 10.1159/000455970
- By:
- Publication type:
- Article
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
- Published in:
- Minerva Urology & Nephrology, 2023, v. 75, n. 4, p. 460, doi. 10.23736/S2724-6051.23.05369-7
- By:
- Publication type:
- Article
A novel immunotherapy prognostic score for patients with pretreated advanced urinary Tract Carcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
- Published in:
- Minerva Urology & Nephrology, 2023, v. 75, n. 3, p. 308, doi. 10.23736/S2724-6051.22.05135-7
- By:
- Publication type:
- Article
Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
- Published in:
- BioDrugs, 2016, v. 30, n. 4, p. 263, doi. 10.1007/s40259-016-0176-3
- By:
- Publication type:
- Article
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 538, doi. 10.1002/1878-0261.13120
- By:
- Publication type:
- Article
The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2017, v. 23, n. 7, p. 755, doi. 10.1177/1076029616668405
- By:
- Publication type:
- Article
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e622, doi. 10.1093/oncolo/oyad337
- By:
- Publication type:
- Article
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e447, doi. 10.1093/oncolo/oyad303
- By:
- Publication type:
- Article